Schizophrenia Research

Schizophrenia is a chronic, debilitating mental disorder affecting 1-2% of the global population. Symptoms are split into two types; 'positive' symptoms, including delusions and hallucinations, and 'negative' symptoms, including anhedonia and lack of motivation. Studies suggest that genetics, early environment, neurobiology, psychological and social processes are important contributory factors; some recreational and prescription drugs appear to cause or worsen symptoms. Several neurobiological alterations in brain structure, physiology and neurochemistry have been documented, along with an ever-increasing list of susceptibility genes.

Schizophrenia Research Products Targets

Products for Schizophrenia Research - Page 50

  1. Cat.No. Product Name Information/Activity
  2. BCC5785 pep2-SVKE 1315378-76-7 pep2-SVKE chemical structure
  3. BCC5783 pep4c 243843-43-8 pep4c chemical structure
  4. BCC4824 Piracetam Piracetam (UCB-6215) is a cyclic derivative of the neurotransmitter gamma-aminobutyric acid (GABA), used in treatment of a wide range of cognitive disorders. Piracetam chemical structure
  5. BCC6940 ATPA ATPA is a selective glutamate receptor GluR5 activator with EC50s of 0.66, 9.5, 1.4, 23, 32, 18, and 14 μM for GluR5wt, GluR5(S741M), GluR5(S721T), GluR5(S721T, S741M), GluR5(S741A), GluR5(S741L), and GluR5(S741V), respectively. ATPA chemical structure
  6. BCC6586 Domoic acid 14277-97-5 Domoic acid chemical structure
  7. BCC6597 (S)-(-)-5-Iodowillardiine 140187-25-3 (S)-(-)-5-Iodowillardiine chemical structure
  8. BCC6572 Kainic acid Kainic acid is a potent agonist at excitatory amino acid receptor subtypes in the CNS. Kainic acid chemical structure
  9. BCC7297 MNI caged kainic acid 1315378-75-6 MNI caged kainic acid chemical structure
  10. BCC7462 ACET 936095-50-0 ACET chemical structure
  11. BCC7275 NS 3763 70553-45-6 NS 3763 chemical structure

Items 491 to 500 of 709 total